首页/数据集/Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 nsp14 peptide (orf1ab)6420-6434

Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 nsp14 peptide (orf1ab)6420-6434

NIAID Data Ecosystem2026-05-02 收录

HLA分子呈递

新冠病毒免疫

数据链接：

https://www.rcsb.org/structure/8CMG 数据链接链接失效反馈

官方服务：

资源简介：

Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 nsp14 peptide (orf1ab)6420-6434

应用场景：

创建时间：

2024-11-13

mRNA疫苗开发

新冠病毒免疫

Because of the rapid mutations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an effective vaccine against SARS-CoV-2 variants is needed to prevent coronavirus disease 2019 (COVID-19

NIAID Data Ecosystem40

DataSheet_5_Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2.pdf

抗体依赖性细胞吞噬作用

新冠病毒免疫

Spike-specific antibodies are central to effective COVID19 immunity. Research efforts have focused on antibodies that neutralize the ACE2-Spike interaction but not on non-neutralizing antibodies. Anti

NIAID Data Ecosystem20

SARS-CoV-2 Spike-derived peptide S269-277 (YLQPRTFLL) presented by HLA-A*02:01

新冠病毒免疫

HLA-肽复合物

SARS-CoV-2 Spike-derived peptide S269-277 (YLQPRTFLL) presented by HLA-A*02:01 Descriptor: Beta-2-microglobulin, HLA class I antigen, Spike protein S1 Authors: Szeto, C, Nguyen, A.T, Gras, S. Deposit

Protein Data Bank Japan2024-10-30 更新20

SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort

新冠病毒免疫

感染风险评估

To identify the potential for SARS-CoV-2 reinfection

DataCite Commons2022-12-21 更新20

Mtb peptides associated with sHLA-E.

结核病免疫

HLA分子呈递

Mtb peptides associated with sHLA-E.

NIAID Data Ecosystem20